Follow
Hubert Fernandez
Hubert Fernandez
Director, Center for Neurological Restoration, Cleveland Clinic
Verified email at ccf.org
Title
Cited by
Cited by
Year
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results
CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ...
Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008
50842008
Genome-wide association study reveals genetic risk underlying Parkinson's disease
J Simon-Sanchez, C Schulte, JM Bras, M Sharma, JR Gibbs, D Berg, ...
Nature genetics 41 (12), 1308-1312, 2009
20082009
Rotenone, paraquat, and Parkinson’s disease
CM Tanner, F Kamel, GW Ross, JA Hoppin, SM Goldman, M Korell, ...
Environmental health perspectives 119 (6), 866-872, 2011
14062011
The Parkinson progression marker initiative (PPMI)
K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ...
Progress in neurobiology 95 (4), 629-635, 2011
11772011
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
CW Olanow, K Kieburtz, P Odin, AJ Espay, DG Standaert, HH Fernandez, ...
The Lancet Neurology 13 (2), 141-149, 2014
6172014
Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial
MS Okun, HH Fernandez, SS Wu, L Kirsch‐Darrow, D Bowers, F Bova, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
5572009
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group
B Ravina, K Marder, HH Fernandez, JH Friedman, W McDonald, ...
Movement Disorders 22 (8), 1061-1068, 2007
5052007
Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers
MS Okun, M Tagliati, M Pourfar, HH Fernandez, RL Rodriguez, ...
Archives of neurology 62 (8), 1250-1255, 2005
4632005
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data
HC Fung, S Scholz, M Matarin, J Simón-Sánchez, D Hernandez, A Britton, ...
The Lancet Neurology 5 (11), 911-916, 2006
4452006
Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial
MS Troche, MS Okun, JC Rosenbek, N Musson, HH Fernandez, ...
Neurology 75 (21), 1912-1919, 2010
3942010
Dissociating apathy and depression in Parkinson disease
L Kirsch-Darrow, HF Fernandez, M Marsiske, MS Okun, D Bowers
Neurology 67 (1), 33-38, 2006
3752006
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ...
JAMA neurology 70 (10), 1277-1287, 2013
3682013
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
IH Richard, MP McDermott, R Kurlan, JM Lyness, PG Como, N Pearson, ...
Neurology 78 (16), 1229-1236, 2012
3462012
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
P Ponikowski, BA Kirwan, SD Anker, T McDonagh, M Dorobantu, ...
The Lancet 396 (10266), 1895-1904, 2020
3322020
Donepezil for dementia in Parkinson’s disease: a randomised, double blind, placebo controlled, crossover study
B Ravina, M Putt, A Siderowf, JT Farrar, M Gillespie, A Crawley, ...
Journal of Neurology, Neurosurgery & Psychiatry 76 (7), 934-939, 2005
3322005
Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors
V Voon, M Pessiglione, C Brezing, C Gallea, HH Fernandez, RJ Dolan, ...
Neuron 65 (1), 135-142, 2010
3122010
SNCA variants are associated with increased risk for multiple system atrophy
SW Scholz, H Houlden, C Schulte, M Sharma, A Li, D Berg, A Melchers, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
2992009
A controlled trial of rotigotine monotherapy in early Parkinson's disease
Parkinson Study Group
Archives of neurology 60 (12), 1721-1728, 2003
2602003
Dopamine agonists and risk: impulse control disorders in Parkinson's; disease
V Voon, J Gao, C Brezing, M Symmonds, V Ekanayake, H Fernandez, ...
Brain 134 (5), 1438-1446, 2011
2522011
Pathophysiology and treatment of psychosis in Parkinson’s disease: a review
LB Zahodne, HH Fernandez
Drugs & aging 25, 665-682, 2008
2492008
The system can't perform the operation now. Try again later.
Articles 1–20